The value of hyoscine butylbromide in abdominal MR imaging with and without oral magnetic particles

Abdominal Imaging

Volumn 22, Issue 4, 1997, Pages 381-388

  Laniado, M ^a   Gronewaller E ^a   Kopp, A F ^a   Kaminsky, S F ^b   Hamm, B ^c   Jacobsen, T F ^d   Claussen, C D ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

^c HUMBOLDT UNIVERSITY   (Germany)

^d NYCOMED IMAGING AS   (Norway)

Author keywords

Contrast media; Gastrointestinal tract; Hyoscine butylbromide; Iron; Magnetic resonance (MR); MR studies

Indexed keywords

FERRISTENE; NUCLEAR MAGNETIC RESONANCE IMAGING AGENT; SCOPOLAMINE BUTYL BROMIDE; UNCLASSIFIED DRUG;

ABDOMINAL CRAMP; ABDOMINAL TUMOR; ADULT; AGED; ARTICLE; ARTIFACT REDUCTION; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DRUG SAFETY; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; VISUAL IMPAIRMENT;

ABDOMINAL NEOPLASMS; ABDOMINAL PAIN; ADMINISTRATION, ORAL; ADULT; AGED; ARTIFACTS; BUTYLSCOPOLAMMONIUM BROMIDE; CONTRAST MEDIA; FEMALE; HUMANS; IMAGE ENHANCEMENT; INJECTIONS, INTRAVENOUS; INTESTINES; IRON; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MUSCARINIC ANTAGONISTS; OXIDES; PERISTALSIS; PROSPECTIVE STUDIES; SAFETY; SINGLE-BLIND METHOD; SUSPENSIONS; VISION DISORDERS; VOMITING;

EID: 1842301711     PISSN: 09428925     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002619900215     Document Type: Article

References (19)

1. Laniado M, Kornmesser W, Hamm B, Clauss W, Weinmann HJ, Felix R. MR imaging of the gastrointestinal tract: value of Gd-DTPA. AJR 1988;150:817-821
2. Patten RM, Moss AA, Fenton TA, Ellioitt S. OMR, a positive bowel contrast agent for abdominal and pelvic MR imaging: safety and imaging characteristics. JMRI 1992;2:25-34
3. Kaminsky S, Laniado M, Gogoll M, et al. Gadopentetate dimeglumine as a bowel contrast agent: safety and efficacy. Radiology 1991;178:503-508
4. Lönnemark M, Hemmingsson A, Bach-Gansmo T, et al. Superparamagnetic particles as oral contrast medium in magnetic resonance imaging of patients with malignant lymphoma. Acta Radiol 1991;32:232-238
5. Rinck PA, Smevik O, Nilsen G, Klepp O, Onsrud M, Oksendal A, Borseth A. Oral magnetic particles in abdominal and pelvic MRI. Radiology 1991;178:775-779
6. Hahn PF, Stark DD, Lewis JM, et al. First clinical trial of a new superparamagnetic iron oxide for use as an oral gastrointestinal contrast agent in MR imaging. Radiology 1990;175:695-700
7. MacVicar D, Jacobsen TF, Guy R, Husband JE. Phase III trial of oral magnetic particles in MRI of abdomen and pelvis. Clin Radiol 1993;47:183-188
8. Brown JJ, Duncan JR, Heiken JP, et al. Perfluoroctylbromide as a gastrointestinal contrast agent for MR imaging: use with and without glucagon. Radiology 1991;181:455-460
9. Rubin DL, Muller HH, Nino-Murcia M, Sidhu M, Christy V, Young SW. Intraluminal contrast enhancement and MR visualization of the bowel wall: efficacy of PFOB. JMRI 1991;1:371-380
10. Oksendal AN, Bach-Gansmo T, Jacobsen TF, Eide H, Andrew E. Oral magnetic particles. Results from clinical phase II trials in 216 patients. Acta Radiol 1993;34:187-193
11. Lönnemark M, Hemmingsson A, Bach-Gansmo T, et al. Effect of superparamagnetic particles as oral contrast medium at magnetic resonance imaging. A phase I clinical study. Acta Radiol 1989;30:193-196
12. Altman DC. Practical statistics for medical research. London, UK: Chapman & Hall, 1991:210-211
13. Feinstein AR. Clinical epidemiology: the architecture of clinical research. Philadelphia: WB Saunders, 1985:185
14. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977;33:159-174
15. Pels Rijcken TH, Davis MA, Ros PR. Intraluminal contrast agents for MR imaging of the abdomen and pelvis. JMRI 1994;4:291-300
16. Herxheimer A, Haffeli L. Human pharmacology of hyoscine butylbromide. Lancet 1966;ii:418-421
17. Thomas AMK, Kubie AM, Britt RP. Acute angioneurotic oedema following a barium meal. Br J Radiol 1986;59:1055-1056
18. Liu MS, Long, DM. Perfluoroctylbromide as a diagnostic contrast medium in gastroenterography. Radiology 1977;122:71-76
19. Van Beers B, Grandin C, Jamart J, Demeure R, Jacobsen TF, Pringot J. Magnetic resonance imaging of lower abdominal and pelvic lesions: assessment of oral magnetic particles as an intestinal contrast agent. Eur J Radiol 1992;14:252-257